Q: Valeant continues to struggle and its on going battle with Allergen doesn't seem to be going anywhere. You have mentioned previously that even if the Allergen deal goes through, the new company will be risky given the debt load. As I already down on this stock, would now be a good time to sell and purchase Concordia or Knight since the risk profiles may not end up being that different?
Thanks for the superb service.
Paul F.
Thanks for the superb service.
Paul F.